Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 10, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for January 6, 2006 Subscribe to this News Feed    
 

Harrington Chiropractic, PC and Laser Therapy Center of Brooklyn, Iowa is the First in the State to Offer Class IV Therapeutic Laser Therapy

Progressive health care providers across the country are quickly learning the benefits of laser therapy, which provides favorable clinical outcomes for a variety of neuromusculoskeletal conditions. Up to now therapeutic lasers were classified as Class III due to their low power. The Avicenna Class IV Therapeutic Laser delivers substantial power and penetration to deliver photons to the target tissues.

(PRWEB) January 6, 2006 -- Harrington Chiropractic, PC and Laser Therapy Center of Brooklyn, Iowa becomes the first health care provider in the state to offer the revolutionary FDA cleared Avicenna Class IV Therapeutic Laser. This technological breakthrough in health care and pain management is already helping numerous other care providers and professional sports teams throughout the US.

Dr. Phil Harrington is proud to be the first health care provider of any type in the state of Iowa to offer Class IV Therapeutic Laser Therapy to his patients. "We can help many more people than we could before. The Avicenna Class IV Laser is absolutely the best thing to ever happen to our office. It is very exciting to help people get the results they want, and with no side effects", said Dr. Harrington.

To this point, therapeutic lasers were classified as Class III by the FDA, since their power output was under 500 milliwatts. The Avicenna Class IV Therapeutic Laser delivers 7500 milliwatts of a 980 nanometer infrared laser, producing penetration of photons up to 2 inches deep in the body.

Laser therapy works by stimulating production of cellular energy in damaged cells and by enhancing the cell membrane permeability. This promotes the speed and the quality of healing, enhances the exchange of nutrients and wastes across the cell membrane and improves elasticity of injured tissues.

Avicenna is the first laser company to gain FDA clearance for a Class IV therapeutic laser. Avicenna’s laser technology delivers 1500 times more power over a treatment region that is over 250 times larger compared to the best selling US Class III Therapeutic Laser. Additionally, it also penetrates this healing energy at 10 times the depth below the skin.

Chiropractors, prolotherapists, osteopaths and podiatrists are among the health care providers currently offering the Avicenna Class IV Laser to their patients. Patients and doctors seeking further information on the Avicenna laser are encouraged to visit his website at http://www.iowalaserdoctor.com.

###

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Dr. Phil Harrington
HARRINGTON CHIROPRACTIC, PC
641-522-9220
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright